Why the study?
Does metformin increase the risk of lactic acidosis in patients with type 2 diabetes and heart failure?
Does metformin increase the risk of lactic acidosis in patients with type 2 diabetes and heart failure?
Answers are grounded in this paper and cite their sources.
Recent changes in prescribing information have removed the contraindication for metformin in patients with type 2 diabetes and heart failure due to a miniscule risk of lactic acidosis.
We recently learned of an important change in the prescribing information for metformin, previously contraindicated in patients with type 2 diabetes accompanied by heart failure (HF) requiring pharmacological therapy. The contraindication was introduced to the label soon after the drug's U.S. release, when case reports emerged of HF patients taking metformin who developed lactic acidosis. It was never clear, however, whether either the HF or the medication were contributing factors. Subsequent analyses revealed a miniscule risk of lactic acidosis associated with metformin …
No takes yet. Share an insight, caveat, or question.
Inzucchi et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: